Topics

Latest "Lung Cancer Research Funding News Magazine Raises Question" News Stories - Page: 4

01:02 EST 28th February 2020 | BioPortfolio

Here are the most relevant search results for "Lung Cancer Research Funding News Magazine Raises Question" found in our extensive news archives from over 250 global news sources.

More Information about Lung Cancer Research Funding News Magazine Raises Question on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Lung Cancer Research Funding News Magazine Raises Question for you to read. Along with our medical data and news we also list Lung Cancer Research Funding News Magazine Raises Question Clinical Trials, which are updated daily. BioPortfolio also has a large database of Lung Cancer Research Funding News Magazine Raises Question Companies for you to search.

Showing "Lung Cancer Research Funding News Magazine Raises Question" News Articles 76–100 of 57,000+

Thursday 27th February 2020

Initial Research Shows MRI Can Improve Liquid Biopsy for Brain Tumors

Using MRI can identify which patients can benefit most from the blood test.


Top NY GI Oncologists Spotlight Groundbreaking Research Efforts

Experts from Memorial Sloan Kettering Cancer Center and NYU Langone Health’s Perlmutter Cancer Center highlight some of the exciting research efforts being conducted at their respective institutions.

Tracing the toxic fingerprint of a bacterium in our gut 


Going Viral: Quantifying Viral Vector Attributes with Light Scattering

In this GEN webinar, sponsored by Wyatt Technology, we will discuss how dynamic light scattering (DLS) and multi-angle light scattering combined with size exclusion chromatography (SEC-MALS) or field-flow fractionation (FFF-MALS) characterize AAV, LV, and other gene delivery vectors. The post Going Viral: Quantifying Viral Vector Attributes with Light Scattering appeared first on GEN - Genetic Eng...

FDA Grants Breakthrough Therapy Status to Debiopharm’s Debio 1143 for Front-Line Treatment of Head and Neck Cancer

LAUSANNE, Switzerland, Feb. 27, 2020 /PRNewswire/ — Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, today announced that the American Food and Drug Administration (FDA) has granted a Breakthrough Therapy Designation for Debio 1143, the most clinically advanced IAP antagonist, for the treatment of patients with confirmed diagnosis of previously untreated, unr...

The American Journal of Managed Care® Highlights New Directions in Immunization Awareness and Engagement

Two executives from the National Alliance of Healthcare Purchasers Coalitions lend perspective on the role of employers in promoting high-value preventive care. The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, offers in-depth perspective on the value of immunization in the evolving health care landscape. A recent...

FDA Grants Tessa’s CAR-T Cell Therapy Regenerative Medicine Advanced Therapy Designation for Treatment of Classical Hodgkin Lymphoma

SINGAPORE, Feb. 27, 2020 /PRNewswire/ — Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced that the Company’s investigational CD30-directed autologous chimeric antigen receptor T cell (CD30 CAR-T) therapy has been granted Regenerative Medicine Advanced Therapy (RMAT) designation by the U.S. Food and Drug Admin...

Altasciences Adds Comprehensive Contract Manufacturing and Analytical Services to its Early Phase Research Offering

Altasciences, a mid-size CRO specializing in a flexible, innovative approach to providing comprehensive early stage drug development from lead candidate selection to proof of concept, today announced that it has acquired

Acadia Healthcare to Present at the Raymond James 41st Annual Institutional Investors Conference

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will present at the Raymond James 41st Annual Institutional Investors Conference, which takes place March 1 - 4, 2020, in Orlando, Florida. In connection with the conference, there will be an on-line webcast of the Company’s presentation available on the Company’s website starting at 4:35 p.m. Eastern Time / 3:35 ...

Imagin Medical Reports Fiscal 2020 First Quarter Results

VANCOUVER, BC and BOSTON, MA / ACCESSWIRE / February 27, 2020 / Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) ("Imagin" or the "Company") today reported financial results for the three months ended December 31, 2019. All amounts, unless otherwise specified, are expressed in Canadian dollars and are presented in accordance with International Fin...

Medicare Beneficiaries Get Few Home Visits After ICU Stay

Medicare beneficiaries are receiving a low number of rehabilitation visits in the early posthospitalization period after critical illness, an analysis of hospital and home health claims data suggests. Medscape Medical News

More Research Required to Determine Best Practices in High-Risk Myeloma

Andrew Branagan, MD, discusses the evolving role of transplant and ongoing research in high-risk multiple myeloma.

Acacia Pharma Announces FDA Approval of Barhemsys for Treatment and Prevention of Postoperative Nausea and Vomiting

Cambridge, UK and Indianapolis, US – 27 February 2020: Acacia Pharma Group plc (“Acacia Pharma” or the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures, or cancer chemotherapy, announces that t...

HBV: Rethink the Free Pass for Immune-Tolerant Patients

There might well be a cure for hepatitis B in coming years, just like there is now for hepatitis C, an expert reports. Medscape Medical News

Europe’s no 1 trade fair for the fine and speciality chemicals industry returns to Cologne with a strong line-up

Chemspec Europe, the International Exhibition for Fine and Speciality Chemicals, returns to Cologne for its 35th edition. From 27 – 28 May 2020, renowned manufacturers, suppliers and distributors of fine and speciality chemicals present their latest products, services and research findings to a dedicated audience of industry experts. The post Europe’s no

Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2019 Financial Results and Conference Call

MINNEAPOLIS, MN / ACCESSWIRE / February 27, 2020 / Celcuity Inc. (NASDAQ:CELC), a functional cellular analysis company that is developing companion diagnostic tests designed to expand the eligible patient populations for targeted therapies, announced that it will release its financial results for the fourth quarter and fiscal year 2019 after the stock market close on Thursday, March 12, 2020. Mana...

Completing Multimodal Therapy Curbs Postop Complications in Advanced Gastric Cancer

In patients with advanced gastric cancer, completing multimodal therapy (MMT) may boost survival by reducing major postoperative complications (POCs), a registry study suggests. Reuters Health Information

Global Market for Personal Computing Devices Will Be Impacted by COVID-19, According to IDC

With 2019 in the rearview mirror and the emergence of the COVID-19 virus, International Data Corporation (IDC) has lowered its forecast for personal computing devices (PCDs), inclusive of desktops, notebooks, workstations, and tablets. According to new projections from the

FDA Advisory Committee Votes in Favor of Lilly’s Cyramza as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

INDIANAPOLIS, Feb. 26, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 6-5 that CYRAMZA® (ramucirumab) plus erlotinib demonstrated a favorable benefit/risk profile for patients with untreated metastatic EGFR-positive non-small cell lung cancer (NSCLC), based on the res...

Everyone needs rudimentary statistical training

Every day we get bombarded in the news with health statistics. Coffee causes cancer! Coffee cures cancer! And so on. Many of these are meant to grab headlines (and, these days, web page clicks), and the articles they accompany are often very poor at telling the reader what they mean. They often have statistics, and […] Find jobs at Careers by KevinMD.com. Search thousands of physician, PA,...

DNA Script Presents New Data Demonstrating the Feasibility of the Company’s Enzymatic Synthesis Technology

The company can now synthesize oligos up to 280nt in length with a cycle efficiency of 99.4% — on DNA Script’s proprietary platform, molecular biology researchers will be able to go from design to results in hours rather than days. DNA Script today announced the presentation of new data in support of the company’s innovative enzymatic DNA synthesis (EDS) technology. The data demonstrate th...

axialHealthcare Announces $15 Million in Series C Funding to Support Expansion into Substance Use Disorder Treatment and Recovery Sector

The company also unveils new branding to reflect expanded scope axialHealthcare, a care optimization company navigating substance use issues for patients, providers, and health plans, today announced it has closed $15 million in equity financing to accelerate its expansion into the substance use disorder (SUD) treatment and recovery sector, led by previous institutional investors Oak HC/FT, .406...

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

A new, phase I clinical trial offered The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute will treat patients with relapsed or refractory acute myeloid leukemia using a novel universal natural killer cell approach.

DGAP-News: Isracann Biosciences Inc.: Isracanns Geschäftsleitung führt in Israel Ortsbesichtigung durch und trifft potenzielle Kunden (deutsch)

Isracann Biosciences Inc.: Isracanns Geschäftsleitung führt in Israel Ortsbesichtigung durch und trifft potenzielle Kunden DGAP-News: Isracann Biosciences Inc. / Schlagwort(e): Research Update Isra...

The LVNG With Lung Cancer (#LVNGWith) community connects & activates people living with #lungcancer and their loved ones to help fight feelings of despair and isolation. #GiftedDay #LCSM http://bit.ly/394idVn pic.twitter.com/UjpRCkwlnw

The LVNG With Lung Cancer ( #LVNGWith) community connects & activates people living with #lungcancer and their loved ones to help fight feelings of despair and isolation. #GiftedDay #LCSM http://bit.ly/394idVn  pic.twitter.com/UjpRCkwlnw


Quick Search

News Quicklinks